New York panel seeks extra Medicaid rebates from Biogen for pricey rare disease drug - STAT

New York panel seeks extra Medicaid rebates from Biogen for pricey rare disease drug - STAT

More reads

• New York panel seeks extra Medicaid rebates from Biogen for pricey rare disease drug. (STAT Plus)
• Moderna’s coronavirus vaccine begins final-stage testing. (Wall Street Journal)
• EU talks with Pfizer, Sanofi, J&J on COVID vaccines hit snags. (Reuters)
• Opinion: Boosting the promise — and reining in the peril — of Covid-19 preprints. (STAT)